PTPA and neurodegenerative disease: Dysfunction of PP2A holoenzyme is involved in the pathogenesis of various diseases, including cancer and neurodegenerative diseases, and, notably, the suppression of PP2A activity is essential for the oncogenesis of human cells (2, 3).